These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7508025)

  • 1. Effect of hypothalamic lesions on interaction of centrally administered ANF and the circulating sodium-pump inhibitor.
    Songu-Mize E; Bealer SL
    J Cardiovasc Pharmacol; 1993; 22 Suppl 2():S4-6. PubMed ID: 7508025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Centrally administered ANF promotes appearance of a circulating sodium pump inhibitor.
    Songu-Mize E; Bealer SL; Hassid AI
    Am J Physiol; 1990 Jun; 258(6 Pt 2):H1655-9. PubMed ID: 2163216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kaliuretic peptide: the most potent inhibitor of Na(+)-K+ ATPase of the atrial natriuretic peptides.
    Chiou S; Vesely DL
    Endocrinology; 1995 May; 136(5):2033-9. PubMed ID: 7720651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Centrally-induced vasopressor responses to sodium-potassium adenosine triphosphatase inhibitor, ouabain, may be mediated via angiotensin II in the anteroventral third ventricle in the brain.
    Takahashi H; Iyoda I; Takeda K; Sasaki S; Okajima H; Yamasaki H; Yoshimura M; Ijichi H
    Jpn Circ J; 1984 Nov; 48(11):1243-50. PubMed ID: 6094853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signaling pathways involved in atrial natriuretic factor and dopamine regulation of renal Na+, K+ -ATPase activity.
    Correa AH; Choi MR; Gironacci M; Valera MS; Fernández BE
    Regul Pept; 2007 Jan; 138(1):26-31. PubMed ID: 17005263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of aortic atrial natriuretic factor and angiotensinogen in experimental hypertension.
    Ogawa T; Linz W; Schölkens BA; de Bold AJ
    J Cardiovasc Pharmacol; 1998 Dec; 32(6):1001-8. PubMed ID: 9869508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of atrial natriuretic factor on Na+-K+-Cl- cotransport of vascular smooth muscle cells.
    Owen NE; Bush EN; Holleman W; O'Donnell ME
    Hypertension; 1987 Nov; 10(5 Pt 2):I128-30. PubMed ID: 2824361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dimethyl sulfoxide inhibits renal Na(+)-K(+)-ATPase at a site different from ouabain and atrial peptides.
    Chiou S; Vesely DL
    Life Sci; 1995; 57(10):945-55. PubMed ID: 7643719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of atrial natriuretic factor on cyclic GMP content in the rat aortic smooth muscle: studies on the role of membrane Na+,K+-ATPase.
    Hedge SS; DeFeo ML; Jandhyala BS
    Clin Exp Pharmacol Physiol; 1989 Aug; 16(8):623-9. PubMed ID: 2551548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atrial natriuretic factor modulates the plasma levels of a Na+/K+ATPase inhibitor in volume expanded borderline hypertensives.
    Borghi C; Boschi S; Costa FV; Ambrosioni E
    Am J Hypertens; 1991 Jul; 4(7 Pt 1):618-22. PubMed ID: 1651740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the hypothalamus in the control of atrial natriuretic peptide release.
    Baldissera S; Menani JW; dos Santos LF; Favaretto AL; Gutkowska J; Turrin MQ; McCann SM; Antunes-Rodrigues J
    Proc Natl Acad Sci U S A; 1989 Dec; 86(23):9621-5. PubMed ID: 2531900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Periventricular forebrain mechanisms for blood pressure regulation.
    Buggy J; Huot S; Pamnani M; Haddy F
    Fed Proc; 1984 Jan; 43(1):25-31. PubMed ID: 6360715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Centrally applied atrial natriuretic factor diminishes bile secretion in the rat.
    Bianciotti LG; Vatta MS; Vescina C; Trippodi V; Sabbatini ME; Fernandez BE
    Regul Pept; 2001 Dec; 102(2-3):127-33. PubMed ID: 11730985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain renin-angiotensin system and the hypothalamic, digitalis-like Na+, K+-ATPase inhibitor in rats.
    Takahashi H; Matsusawa M; Ikegaki I; Nishimura M; Yoshimura M; Yamada H; Sano Y
    Clin Exp Hypertens A; 1988; 10(6):1285-7. PubMed ID: 2852080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrial natriuretic peptide regulates release of Na+-K+-ATPase inhibitor from rat brain.
    Crabos M; Ausiello DA; Haupert GT; Cantiello HF
    Am J Physiol; 1988 Jun; 254(6 Pt 2):F912-7. PubMed ID: 2837911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atrial natriuretic factor inhibits luteinizing hormone secretion in the rat: evidence for a hypothalamic site of action.
    Samson WK; Aguila MC; Bianchi R
    Endocrinology; 1988 Apr; 122(4):1573-82. PubMed ID: 2964365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of AV3V lesions on development of DOCA-salt hypertension and vascular Na+-pump activity.
    Songu-Mize E; Bealer SL; Caldwell RW
    Hypertension; 1982; 4(5):575-80. PubMed ID: 6286476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mechanism of Na+, K+-ATPase inhibition by atrial natriuretic factor in rat renal medulla.
    Bełtowski J; Górny D; Marciniak A
    J Physiol Pharmacol; 1998 Jun; 49(2):271-83. PubMed ID: 9670110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of DOCA-salt treatment duration and anteroventral third ventricle lesions on a plasma-borne sodium pump inhibitor in rats.
    Songu-Mize E; Bealer SL; Caldwell RW
    J Hypertens; 1987 Aug; 5(4):461-7. PubMed ID: 3668248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction between atrial natriuretic factor and ouabain: vascular reactivity to noradrenaline in pentobarbital anaesthetized dogs.
    Chintala MS; Jandhyala BS
    Clin Exp Pharmacol Physiol; 1988 Aug; 15(8):591-9. PubMed ID: 2978748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.